ACTRN12619000782134已完成1 期
A Randomised Control Trail to compare the infection rate in topical use of antibiotic vs conventional management of open fractures groups.
Modilon General Hospital0 个研究点目标入组 120 人开始时间: 2019年5月27日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
Results: We recorded a significant reduction of infection rate on the 2nd and 6th week, but non-significant reduction at 6th month in the topical group compared to the non-topical group. As comparted to the non-topical group, in the topical group we recorded the reduced number of procedures, the length of hospital stay, and the rate of non-unions at 6-month follow-up. A specific feature of our participants was long delay tothefisrt debridement. Our study contributed to building evidence that adding topical antibiotic to standard protocol reduce infection rate in open fractures.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 10 Years 至 60 Years(—)
- 性别
- All
入选标准
- •We include all consecutive patients diagnosed clinically and radiologically as open long bone fracture of GA type II or III (A &B)
排除标准
- •Patients with evident infection or sub clinical infection and immunosuppressed
研究者
相似试验
已完成
2 期
Dose Ranging Safety and Efficacy of Therapeutic HSV-2 VaccineGenital Herpes Simplex Type 2NCT02114060Genocea Biosciences, Inc.310
进行中(未招募)
1 期
3 or 6 cycles of platinum-based chemotherapy prior to maintenance avelumab for bladder cancernresectable locally advanced or metastatic urothelial carcinomaMedDRA version: 20.0Level: LLTClassification code 10046714Term: Urothelial carcinoma bladderSystem Organ Class: 100000004864EUCTR2021-001975-17-ESQueen Mary University of London224
已完成
不适用
A study on relapse of the symptom comparing 2 weeks and 8 weeks of treatment period in GERD patients using the newly established GerdQ questionnairesGERDJPRN-UMIN000008551Tokai University School of Medicine80
已完成
3 期
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)Pancreatic NeoplasmsNeoplasmsEndocrine Gland NeoplasmsPancreatic DiseasesDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesEndocrine System DiseasesGemcitabineAntimetabolites, AntineoplasticNCT01964430Celgene866
已完成
不适用
The Safety and Effectiveness of Indinavir Sulfate Plus EfavirenzHIV InfectionsNCT00002387Merck Sharp & Dohme LLC80
